Determinants on Major Histocompatibility Complex Class I Molecules Recognized by Cytotoxic T Lymphocytes

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The antigen specificity of cytotoxic T lymphocytes (CTL) cells is a result of the recognition of class I molecules on target cells that are encoded by genes in the major histocompatibility complex (MHC). These molecules consist of a 40,000–45,000 Da heavy chain noncovalently bound to a 12,000 Da light chain, β2-microgIobulin (β2-M). Although class I molecules expressed by an individual are invariant, the alleles of each gene that encode class I molecules are highly polymorphic such that most species possess a large number of antigenically diverse class I alloantigens. The polymorphism found in class I molecules is not randomly distributed, but rather localized to the α1 and α2 domains. In contrast to the class I heavy chain, β2-M is invariant within a species, although in the mouse limited polymorphism has been detected. Although class I molecules within a species are ∼80–90% homologous, the fact that T cells readily distinguish among class I alloantigens indicates that the immune system focuses on the polymorphic features of these molecules. To accomplish this, CTL utilize α and β chains of their T cell receptor to recognize antigen in the context of class I molecules. This chapter examines the various approaches used to characterize determinants on class I molecules that are recognized by both alloreactive and antigen-specific class I-restricted CTL. Studies attempting to examine the nature of the determinants recognized by CTL have taken advantage of the variants of normal class I molecules. The role of carbohydrates and β2-M in controlling epitopes recognized by CTL are discussed in the chapter.

Original languageEnglish (US)
Pages (from-to)135-179
Number of pages45
JournalAdvances in Immunology
Volume41
Issue numberC
DOIs
StatePublished - Jan 1 1987

Fingerprint

Cytotoxic T-Lymphocytes
Major Histocompatibility Complex
Isoantigens
MHC Class I Genes
Antigens
Histocompatibility Antigens Class I
T-Cell Antigen Receptor
Epitopes
Immune System
Alleles
Carbohydrates
T-Lymphocytes
Light
Genes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Determinants on Major Histocompatibility Complex Class I Molecules Recognized by Cytotoxic T Lymphocytes. / Forman, James.

In: Advances in Immunology, Vol. 41, No. C, 01.01.1987, p. 135-179.

Research output: Contribution to journalArticle

@article{ccb4f742096542ac95de2aee5cfb4d9a,
title = "Determinants on Major Histocompatibility Complex Class I Molecules Recognized by Cytotoxic T Lymphocytes",
abstract = "The antigen specificity of cytotoxic T lymphocytes (CTL) cells is a result of the recognition of class I molecules on target cells that are encoded by genes in the major histocompatibility complex (MHC). These molecules consist of a 40,000–45,000 Da heavy chain noncovalently bound to a 12,000 Da light chain, β2-microgIobulin (β2-M). Although class I molecules expressed by an individual are invariant, the alleles of each gene that encode class I molecules are highly polymorphic such that most species possess a large number of antigenically diverse class I alloantigens. The polymorphism found in class I molecules is not randomly distributed, but rather localized to the α1 and α2 domains. In contrast to the class I heavy chain, β2-M is invariant within a species, although in the mouse limited polymorphism has been detected. Although class I molecules within a species are ∼80–90{\%} homologous, the fact that T cells readily distinguish among class I alloantigens indicates that the immune system focuses on the polymorphic features of these molecules. To accomplish this, CTL utilize α and β chains of their T cell receptor to recognize antigen in the context of class I molecules. This chapter examines the various approaches used to characterize determinants on class I molecules that are recognized by both alloreactive and antigen-specific class I-restricted CTL. Studies attempting to examine the nature of the determinants recognized by CTL have taken advantage of the variants of normal class I molecules. The role of carbohydrates and β2-M in controlling epitopes recognized by CTL are discussed in the chapter.",
author = "James Forman",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/S0065-2776(08)60031-0",
language = "English (US)",
volume = "41",
pages = "135--179",
journal = "Advances in Immunology",
issn = "0065-2276",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - Determinants on Major Histocompatibility Complex Class I Molecules Recognized by Cytotoxic T Lymphocytes

AU - Forman, James

PY - 1987/1/1

Y1 - 1987/1/1

N2 - The antigen specificity of cytotoxic T lymphocytes (CTL) cells is a result of the recognition of class I molecules on target cells that are encoded by genes in the major histocompatibility complex (MHC). These molecules consist of a 40,000–45,000 Da heavy chain noncovalently bound to a 12,000 Da light chain, β2-microgIobulin (β2-M). Although class I molecules expressed by an individual are invariant, the alleles of each gene that encode class I molecules are highly polymorphic such that most species possess a large number of antigenically diverse class I alloantigens. The polymorphism found in class I molecules is not randomly distributed, but rather localized to the α1 and α2 domains. In contrast to the class I heavy chain, β2-M is invariant within a species, although in the mouse limited polymorphism has been detected. Although class I molecules within a species are ∼80–90% homologous, the fact that T cells readily distinguish among class I alloantigens indicates that the immune system focuses on the polymorphic features of these molecules. To accomplish this, CTL utilize α and β chains of their T cell receptor to recognize antigen in the context of class I molecules. This chapter examines the various approaches used to characterize determinants on class I molecules that are recognized by both alloreactive and antigen-specific class I-restricted CTL. Studies attempting to examine the nature of the determinants recognized by CTL have taken advantage of the variants of normal class I molecules. The role of carbohydrates and β2-M in controlling epitopes recognized by CTL are discussed in the chapter.

AB - The antigen specificity of cytotoxic T lymphocytes (CTL) cells is a result of the recognition of class I molecules on target cells that are encoded by genes in the major histocompatibility complex (MHC). These molecules consist of a 40,000–45,000 Da heavy chain noncovalently bound to a 12,000 Da light chain, β2-microgIobulin (β2-M). Although class I molecules expressed by an individual are invariant, the alleles of each gene that encode class I molecules are highly polymorphic such that most species possess a large number of antigenically diverse class I alloantigens. The polymorphism found in class I molecules is not randomly distributed, but rather localized to the α1 and α2 domains. In contrast to the class I heavy chain, β2-M is invariant within a species, although in the mouse limited polymorphism has been detected. Although class I molecules within a species are ∼80–90% homologous, the fact that T cells readily distinguish among class I alloantigens indicates that the immune system focuses on the polymorphic features of these molecules. To accomplish this, CTL utilize α and β chains of their T cell receptor to recognize antigen in the context of class I molecules. This chapter examines the various approaches used to characterize determinants on class I molecules that are recognized by both alloreactive and antigen-specific class I-restricted CTL. Studies attempting to examine the nature of the determinants recognized by CTL have taken advantage of the variants of normal class I molecules. The role of carbohydrates and β2-M in controlling epitopes recognized by CTL are discussed in the chapter.

UR - http://www.scopus.com/inward/record.url?scp=0023567532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023567532&partnerID=8YFLogxK

U2 - 10.1016/S0065-2776(08)60031-0

DO - 10.1016/S0065-2776(08)60031-0

M3 - Article

C2 - 2446478

AN - SCOPUS:0023567532

VL - 41

SP - 135

EP - 179

JO - Advances in Immunology

JF - Advances in Immunology

SN - 0065-2276

IS - C

ER -